TIGIT, CTLA-4, PD-1, T cell immunoglobulin 3 (Tim3), and lymphocyte activation gene 3 (LAG3) are the most commonly targeted checkpoints for cancer immunotherapy [45]. Here, HAVCR2 is linked to cancer.